Іздеу

Шығарылым
Атауы
Авторлар
№ 2 (2016)
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.
PDF
(Rus)
№ 5 (2015)
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N., Ivanova L., Abaeva F.
PDF
(Rus)
№ 16 (2014)
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
PDF
(Rus)
№ 5 (2014)
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N., Kuzina I.
PDF
(Rus)
№ 16 (2013)
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M., Derevyanchenko M.
PDF
(Rus)
№ 10 (2013)
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
PDF
(Rus)
№ 5 (2013)
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
PDF
(Rus)
№ 16 (2012)
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Dorofeeva L.
PDF
(Rus)
№ 16 (2012)
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
PDF
(Rus)
№ 9 (2012)
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A., Vorozhtsova E., Orlova T.
PDF
(Rus)
№ 3 (2012)
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.
№ 16 (2011)
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.
№ 16 (2010)
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A., Rudakova A.
№ 17 (2009)
ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2
Petunina N., Antsiferov M.
№ 3 (2009)
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.
Том 31, № 8 (2024)
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.
PDF
(Rus)
Том 32, № 2 (2025)
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T., Vezikova N.
PDF
(Rus)
Том 31, № 2 (2024)
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I., Boeva V.
PDF
(Rus)
Том 30, № 12 (2023)
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
PDF
(Rus)
Том 30, № 12 (2023)
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.
PDF
(Rus)
Том 30, № 3 (2023)
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.
PDF
(Rus)
Том 27, № 12 (2020)
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
Shchukina E., Gromenkov V., Suprun Y., Mykhailichenko E., Beryozova E., Bagriy V., Golodnikov I.
PDF
(Rus)
Том 27, № 4 (2020)
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A., Markova T.
PDF
(Rus)
Том 27, № 4 (2020)
The many faces of vitamin D
Verbovoy A., Dolgikh Y., Verbovaya N.
PDF
(Rus)
Том 26, № 4 (2019)
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E., Solovyova I.
PDF
(Rus)
№ 11 (2018)
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y., Zanozin A., Zanozina O., Runov G.
PDF
(Rus)
№ 4 (2018)
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.
PDF
(Rus)
№ 16 (2017)
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E., Antsiferov M.
PDF
(Rus)
№ 5 (2017)
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N., Terekhova A.
PDF
(Rus)
№ 5 (2016)
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
PDF
(Rus)
№ 13 (2015)
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A., Verbovoy A.
PDF
(Rus)
№ 5 (2015)
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
PDF
(Rus)
№ 16 (2014)
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
PDF
(Rus)
№ 5 (2014)
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.
PDF
(Rus)
№ 16 (2013)
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.
PDF
(Rus)
№ 16 (2012)
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
PDF
(Rus)
№ 3 (2012)
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
№ 3 (2011)
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
№ 16 (2010)
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
№ 8 (2010)
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
№ 17 (2009)
SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM
Ametov A., Karpova E.
№ 17 (2009)
MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY
Demidova I., Gorokhova T.
№ 3 (2009)
Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus
Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.
Том 32, № 2 (2025)
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children
Sadykova D., Shaydullina M., Aksenova A., Galimova L.
PDF
(Rus)
Том 31, № 2 (2024)
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.
PDF
(Rus)
Том 30, № 12 (2023)
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.
PDF
(Rus)
Том 29, № 11/12 (2022)
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.
PDF
(Rus)
Том 28, № 12 (2021)
Obesity: an invisible disease
Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.
PDF
(Rus)
Том 26, № 14 (2019)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
PDF
(Rus)
Том 26, № 4 (2019)
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L., Verbovoy A.
PDF
(Rus)
№ 11 (2018)
Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure
Demidova T., Titova V.
PDF
(Rus)
№ 2 (2018)
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y., Martynyuk M.
PDF
(Rus)
№ 16 (2017)
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
PDF
(Rus)
№ 16 (2016)
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PDF
(Rus)
№ 16 (2014)
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
PDF
(Rus)
№ 5 (2014)
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M., Nazhmutdinova P., Ametov A.
PDF
(Rus)
№ 16 (2013)
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N., Ametov A., Antsiferov M.
PDF
(Rus)
№ 5 (2013)
KLINIChESKIE PREIMUShchESTVA PERVOGO ANALOGA ChELOVEChESKOGO GPP-1 LIRAGLUTIDA PRI LEChENII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Demidova I.
PDF
(Rus)
№ 5 (2013)
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L., Lomova A., Ruyatkin D.
PDF
(Rus)
№ 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
№ 3 (2012)
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
№ 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
№ 5 (2011)
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
№ 3 (2011)
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
№ 16 (2010)
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
№ 3 (2010)
Advance - movement forward
Petunina N., Petunina N.
№ 17 (2009)
OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI
Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.
№ 15 (2009)
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
№ 3 (2009)
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
Antsiferov M., Petraneva E., Anciferov M., Petraneva E.
Том 32, № 2 (2025)
Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice
Elsukova O., Nikitina E.
PDF
(Rus)
Том 31, № 2 (2024)
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.
PDF
(Rus)
Том 31, № 2 (2024)
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.
PDF
(Rus)
Том 30, № 12 (2023)
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.
PDF
(Rus)
Том 29, № 11/12 (2022)
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N., Martirosyan N., Valeeva F.
PDF
(Rus)
Том 28, № 12 (2021)
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
PDF
(Rus)
Том 27, № 12 (2020)
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N., Baranova N., Fedin A.
PDF
(Rus)
Том 26, № 4 (2019)
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
PDF
(Rus)
№ 11 (2018)
Apelin: biological and pathophysiological effects
Dolgikh Y., Verbovoy A.
PDF
(Rus)
№ 5 (2017)
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
PDF
(Rus)
№ 5 (2016)
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.
PDF
(Rus)
№ 17 (2015)
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
PDF
(Rus)
№ 10 (2015)
Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
Gusenbekova D., Ametov A., Butaeva S.
PDF
(Rus)
№ 5 (2015)
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.
PDF
(Rus)
№ 5 (2014)
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V., Nichitenko M., Chesnikova A.
PDF
(Rus)
№ 5 (2013)
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
PDF
(Rus)
№ 11 (2012)
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PDF
(Rus)
№ 3 (2012)
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.
№ 16 (2011)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
№ 16 (2010)
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
№ 5 (2010)
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
№ 3 (2010)
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
№ 3 (2009)
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Том 30, № 12 (2023)
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
PDF
(Rus)
Том 30, № 12 (2023)
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
PDF
(Rus)
Том 29, № 4 (2022)
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
PDF
(Rus)
Том 28, № 12 (2021)
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
PDF
(Rus)
Том 27, № 12 (2020)
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T., Lomonova T.
PDF
(Rus)
№ 11 (2018)
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
PDF
(Rus)
№ 17 (2015)
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
PDF
(Rus)
№ 5 (2014)
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M., Koteshkova O.
PDF
(Rus)
Нәтижелер 209 - 101/200 << < 1 2 3 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>